Author:
Garaiova Iveta,Muchová Jana,Nagyová Zuzana,Mišľanová Csilla,Oravec Stanislav,Dukát Andrej,Wang Duolao,Plummer Sue F,Ďuračková Zdeňka
Abstract
Abstract
Background
Assessment of cardiovascular disease (CVD) risk factors can predict clinical manifestations of atherosclerosis in adulthood. In this pilot study with hypercholesterolemic children and adolescents, we investigated the effects of a combination of plant sterols, fish oil and B vitamins on the levels of four independent risk factors for CVD; LDL-cholesterol, triacylglycerols, C-reactive protein and homocysteine.
Methods
Twenty five participants (mean age 16 y, BMI 23 kg/m2) received daily for a period of 16 weeks an emulsified preparation comprising plant sterols esters (1300 mg), fish oil (providing 1000 mg eicosapentaenoic acid (EPA) plus docosahexaenoic acid (DHA)) and vitamins B12 (50 μg), B6 (2.5 mg), folic acid (800 μg) and coenzyme Q10 (3 mg). Atherogenic and inflammatory risk factors, plasma lipophilic vitamins, provitamins and fatty acids were measured at baseline, week 8 and 16.
Results
The serum total cholesterol, LDL- cholesterol, VLDL-cholesterol, subfractions LDL-2, IDL-1, IDL-2 and plasma homocysteine levels were significantly reduced at the end of the intervention period (p<0.05). The triacylglycerols levels decreased by 17.6%, but did not reach significance. No significant changes in high sensitivity C-reactive protein, HDL-cholesterol and apolipoprotein A-1 were observed during the study period. After standardisation for LDL cholesterol, there were no significant changes in the levels of plasma γ-tocopherol, β-carotene and retinol, except for reduction in α-tocopherol levels. The plasma levels of n-3 fatty acids increased significantly with the dietary supplementation (p<0.05).
Conclusions
Daily intake of a combination of plant sterols, fish oil and B vitamins may modulate the lipid profile of hypercholesterolemic children and adolescents.
Trial registration
Current Controlled Trials ISRCTN89549017
Publisher
Springer Science and Business Media LLC
Subject
Nutrition and Dietetics,Medicine (miscellaneous)
Reference38 articles.
1. Allender S, Scarborough P, Peto V, Rayner M, Leal J, Luengo-Fernandez R, Gray A: EHN European cardiovascular disease statistics. 2008, British Heart Foundation Statistics Database, http://www.heartstats.org, edition,
2. Daniels SR, Gidding SS, de Ferranti SD: Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011, 5: S30-S37. 10.1016/j.jacl.2011.03.453.
3. McNeal CJ, Dajani T, Wilson D, Cassidy-Bushrow AE, Dickerson JB, Ory M: Hypercholesterolemia in Youth: Opportunities and obstacles to prevent premature atherosclerotic cardiovascular disease. Curr Atheroscler Rep. 2010, 12: 20-28. 10.1007/s11883-009-0072-0.
4. O’Gorman CSM, O’Neill MB, Conwell LS: Considering statins for cholesterol-reduction in children if lifestyle and diet changes do not improve their health: a review of the risks and benefits. Vasc Health Risk Manag. 2011, 7: 1-14.
5. Gylling H, Siimes MA, Miettinen TA: Sitostanol ester margarine in dietary treatment of children with familial hypercholesterolemia. J Lipd Res. 1995, 36: 1807-1812.